Halting Coronavirus Replication
Epidemiology Open Journal - International Journal of Epidemiology, 2020; 5(1): 13-15. doi: 10.17140/EPOJ-5-119 (Openventio Publishers)
3 Pages Posted: 5 Nov 2020 Last revised: 16 Feb 2021
Date Written: March 18, 2020
Abstract
Sirtuin 1 (SIRT1) inhibitors can reduce replication of many viruses with certain characteristics similar to those of coronaviruses, while the p53 protein is another important factor in the down-regulation of viral growth. Tenovin is a class of small molecules that inhibit Sirtuin 1 and 2, in addition to activating the p53 protein, by means of regulating the interactions used by coronaviruses as a self-defense mechanism. By blocking virus growth and continuous replication, with already tested antiviral medicines, the promise of coronavirus disease 2019 (COVID-19) eradication exists.
Note: Funding: None.
Declaration of Interests: None.
Keywords: P53, Tumor suppressor,P53, Tenovin-6, COVID-19, SARS-CoV2/COVID-19:, COVID-19 Epidemic, Tenovin-1, coronavirus replication, COVID-19 PANDEMIC, SIRT1 inhibitors
Suggested Citation: Suggested Citation